Investors need to pay close attention to Harmonic (HLIT) stock based on the movements in the options market lately.

SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, ...

Analysts have been eager to weigh in on the Technology sector with new ratings on Harmonic (HLIT – Research Report) and Altair Engineering ...

Research analysts at Northland Capmk raised their FY2024 earnings per share (EPS) estimates for Harmonic in a report issued ...

Record revenue with Broadband revenue up 92% year over year Video returned to profitability with greater than 10% Adjusted EBITDA margin SAN JOSE, Calif., Oct. 28 ...

Harmonic (NASDAQ:HLIT – Get Free Report) was downgraded by Raymond James from a “strong-buy” rating to an “outperform” rating ...

Fintel reports that on October 29, 2024, Jefferies downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Buy to Hold.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.26% of ...

Harmonic Inc (HLIT) reports a 54% revenue increase, driven by broadband demand, while addressing future ecosystem integration ...

Raymond James downgraded Harmonic (HLIT) to Outperform from Strong Buy with a price target of $14, down from $17. Published first on TheFly ...

Fintel reports that on October 29, 2024, Raymond James downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Strong Buy ...

For the current quarter ending in December, Harmonic expects its per-share earnings to range from 26 cents to 31 cents. The company said it expects revenue in the range of $205 million to $220 million ...